Covidien

(

COV

) pushed the Health Services industry lower today making it today's featured Health Services loser. The industry as a whole closed the day down 0.2%. By the end of trading, Covidien fell 68 cents (-1.5%) to $43.79 on light volume. Throughout the day, 2.4 million shares of Covidien exchanged hands as compared to its average daily volume of 4.1 million shares. The stock ranged in price between $43.79-$44.69 after having opened the day at $44.69 as compared to the previous trading day's close of $44.47. Other company's within the Health Services industry that declined today were:

Response Genetics Inc

(

RGDX

), down 13.8%,

Misonix Inc

(

MSON

), down 10.1%,

Spherix Inc

(

SPEXD

), down 8%, and

Spherix Inc

(

SPEX

), down 8%.

Covidien Public Limited Company develops, manufactures, and sells healthcare products for use in clinical and home settings in the United States and internationally. Covidien has a market cap of $21.96 billion and is part of the

health care

sector. The company has a P/E ratio of 11.3, below the average health services industry P/E ratio of 12 and below the S&P 500 P/E ratio of 17.7. Shares are down 2.6% year to date as of the close of trading on Monday.

TheStreet Ratings rates Covidien as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, expanding profit margins, solid stock price performance and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the positive front,

Dehaier Medical Systems

(

DHRM

), up 14.3%,

World Heart Corporation

(

WHRT

), up 12.4%,

InfuSystems Holdings Inc

(

INFU

), up 12.1%, and

American Caresource Holdings Inc

(

ANCI

), up 10%, were all gainers within the health services industry with

Baxter International Inc

(

BAX

) being today's featured health services industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

null